PALB2 and infantile convulsions and choreoathetosis: In this report, we presented a case of a patient with advanced ICCA harboring dual somatic HRR gene pathogenic variants, specifically BRCA1 and PALB2, who achieved PR lasting approximately 7 months following salvage treatment with olaparib.